Verzenio
@verzenio.com
Verzenio (abemaciclib) is a treatment for both HR+, HER2-, high risk, node positive early breast cancer and for certain types of HR+, HER2- metastatic breast cancer.
Verzenio's Company Logos
Verzenio's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#00ABC7
Pacific Blue
0, 171, 199
188, 100, 39
100, 14, 0, 22
#79B4F1
Jordy Blue
121, 180, 241
211, 81, 71
50, 25, 0, 5
#007095
Bahama Blue
0, 112, 149
195, 100, 29
100, 25, 0, 42
About Verzenio
Verzenio® is a leading brand offering treatment options for Early Breast Cancer (EBC) with a focus on HR+, HER2– subtype. Understanding your diagnosis is crucial, as EBC is when cancer is localized in the breast or nearby lymph nodes, without spreading. Verzenio® provides insight into the risk factors affecting prognosis, such as tumor size and lymph node involvement.
The brand offers various treatments, including surgery, chemotherapy, radiation, and hormone therapy tailored to your specific needs. Partnering with your doctor is key in selecting the most effective treatment to prevent cancer recurrence. Verzenio® also provides patient stories and support to guide you through your medical journey.
With Verzenio® + hormone therapy, you can address your HR+, HER2–, node-positive EBC effectively. Empower yourself with information and consider Verzenio® as a valuable resource in your treatment plan
